Cellular Logistics collaborates on heart research

UW–Madison physician researchers Amish Raval, M.D. and Tim Kamp, M.D., Ph.D., have been awarded a $765,000 U01 Research Project Cooperative Agreement from the National Institutes of Health. Dr. Raval is the co-founder of Cellular Logistics, which was created to treat heart damage. FujiFilm Cellular Dynamics Inc., a world-leader in stem-cell technologies, is an industry partner.

According to a release, the grant, which will be matched by collaborators with cash and in-kind contributions of research material, cells, and services, will enable the first major pre-clinical study combining Cellular Logistics’ Tandem HF technology and a “well-characterized cardiovascular cell therapy.”

“We anticipate that the study will demonstrate not only the safety and efficacy of this combination, but also the therapeutic improvements Tandem HF provides with its enhanced delivery and retention capabilities. We believe the study and its results will serve as a strong foundation for additional studies that will further refine and advance our technology and its ability to change the lives of health failure patients,” states Alex Vodenlich, president and CEO of Cellular Logistics.